MetalloBio's mission is fundamentally to change the nature of antibiotics and the treatment of infections.
A Royal Society Entrepreneur in Residence at The University of Sheffield and owner of Murray International Partners, Mike has extensive experience in C-suite level management, business development and licensing and has led and closed multiple high-value deals in the life sciences sector.
A Professor of Bioinorganic Chemistry at The University of Sheffield and co-developer of the research that led to the creation of MetalloBio’s antimicrobial technology, Jim advises the ongoing development of MetalloBio’s proprietary antimicrobial technology.
Ross McMASTER is director of Suel Limited and is Fellow of the Association of Chartered Accountants. He has a background in local and national chartered accountancy and specializes in the provision of company structuring, strategic and business planning, management accounting and financial forecasting. Ross has held numerous Directorships and Secretarial positions and has amassed extensive knowledge of the requirements needed to establish successful companies originating from academic ideas through to exit including two IPOs.
With an extensive background in technology transfer and intellectual property management, Richard looks after day to day operations and MetalloBio’s ongoing company development strategy.
Responsible for development and production of MetalloBio’s lead compounds, Simon is an experienced inorganic chemist and holds a PhD in Chemistry and Molecular Biology and Biotechnology from the University of Sheffield.
Responsible for development and production of MetalloBio’s antimicrobial coating technology, Matt is an experienced materials engineer and holds a PhD in Regenerative Medicine and Tissue Engineering from The University of Leeds.